USPTO Examiner STILES AMBER R - Art Unit 2913

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
29974868COMBINED ELECTRIC TOOTHBRUSH SET AND STANDNovember 2024March 2025Allow300NoNo
18584620SONOSENSITIZATIONFebruary 2024August 2024Allow610YesNo
29903626Electric toothbrushSeptember 2023March 2025Allow1800NoNo
29901572TOOTHBRUSH HEADSeptember 2023March 2025Allow1800NoNo
18136036ROTATABLE THROMBUS ENGAGEMENT TOOLApril 2023November 2023Allow720NoNo
29873653ToothbrushApril 2023March 2025Allow2300NoNo
17625813A DISSOLVABLE MICRONEEDLEJanuary 2022August 2024Allow3110YesNo
17436255MICRONEEDLE ARRAY COMPRISING A HEAT-PRODUCING ELEMENTSeptember 2021September 2024Allow3610YesNo
17312504Method and Device for Producing MicroneedlesJune 2021September 2024Allow3910YesNo
17238307DOSE DETECTION FOR A MEDICATION DELIVERY DEVICEApril 2021August 2024Allow3910NoNo
17234926FEEDING TUBE WITH INFLATABLE BALLOON COMPONENT AND AT LEAST ONE OF A CARBON DIOXIDE SAMPLING LINE AND A SUCTION TUBE COMPONENTApril 2021September 2024Allow4120YesYes
17231360MEDICAL INFUSION PUMP TREATMENT IDENTIFICATIONApril 2021September 2024Allow4110NoNo
17188301Medical Agent Dispensing Systems, Methods, and ApparatusesMarch 2021August 2024Allow4110NoNo
17187256PERITONEAL DIALYSATE FLOW PATH SENSINGFebruary 2021September 2024Allow4210NoNo
17174367DELIVERY DEVICE WITH NOISE REDUCING COMPONENTFebruary 2021August 2024Allow4210NoNo
17063575MEDICAMENT TRAINING DEVICE AND SYSTEMOctober 2020July 2024Allow4510YesNo
17027667Dynamic Microvalve Protection DeviceSeptember 2020April 2024Allow4310NoNo
16086727FILTERING SYRINGESeptember 2018March 2020Allow1800NoNo
16083427Determining Device for Determining a Value Representing a Dose of a Dose Metering Device, and a Method for Operating SameSeptember 2018April 2020Allow2000NoNo
15801809Offset Catheter Securement Device With Removable Retention MemberNovember 2017November 2019Allow2421NoNo
15638300Breast Pump Comprising Heating CupJune 2017January 2019Abandon1910NoNo
15629337METHODS AND DEVICES FOR ANALYTE SENSING IN POTENTIAL SPACESJune 2017November 2019Allow2921NoNo
15438270MICROFLOW RESTRICTOR ASSEMBLY AND METHODS OF MAKING THE SAMEFebruary 2017May 2019Allow2611NoNo
15376889MICRONEEDLE UNITDecember 2016August 2019Allow3220NoNo
15368124CANNULA STABILIZATION DEVICEDecember 2016September 2018Allow2210NoNo
15033691SYRINGE FOR SEQUENTIAL INJECTION OF SUBSTANCESAugust 2016February 2020Allow4541YesNo
15054983Selective Stiffening Catheter and Methods for Operating a Selective Stiffening CatheterFebruary 2016September 2018Allow3010YesNo
14783535DRIVE MECHANISM FOR A DRUG DELIVERY DEVICEOctober 2015January 2018Allow2800YesNo
14783010DRIVE MECHANISM FOR A DRUG DELIVERY DEVICEOctober 2015June 2018Allow3210NoNo
14781205DRUG DELIVERY DEVICE WITH INTEGRATED MAGNETIC MOVEMENT INDICATORSeptember 2015May 2018Allow3110YesNo
14648376COMBINATION PLUNGER DEVICE FOR A DUAL CHAMBER MIXING SYRINGEMay 2015March 2018Allow3411YesNo
14105186TRANSPORT AND TRANSFER CONTAINER FOR A LIQUID MEDIUMDecember 2013August 2019Allow6031YesNo
13684118APPARATUS, SYSTEMS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL CONDITIONSNovember 2012October 2018Allow6060YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner STILES, AMBER R..

Strategic Value of Filing an Appeal

Total Appeal Filings
1
Allowed After Appeal Filing
1
(100.0%)
Not Allowed After Appeal Filing
0
(0.0%)
Filing Benefit Percentile
98.1%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner STILES, AMBER R. - Prosecution Strategy Guide

Executive Summary

Examiner STILES, AMBER R. works in Art Unit 2913 and has examined 31 patent applications in our dataset. With an allowance rate of 96.8%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 32 months.

Allowance Patterns

Examiner STILES, AMBER R.'s allowance rate of 96.8% places them in the 90% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by STILES, AMBER R. receive 1.29 office actions before reaching final disposition. This places the examiner in the 24% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by STILES, AMBER R. is 32 months. This places the examiner in the 33% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +5.3% benefit to allowance rate for applications examined by STILES, AMBER R.. This interview benefit is in the 30% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 36.4% of applications are subsequently allowed. This success rate is in the 79% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 60.0% of cases where such amendments are filed. This entry rate is in the 82% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 95% percentile among all examiners. Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 80.0% are granted (fully or in part). This grant rate is in the 92% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 26% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 6.7% of allowed cases (in the 83% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.